Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VPREB1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | C12orf42 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | NCKAP1L | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | ZNF132 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | SLAIN2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | ANK1 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | SMIM24 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | STX11 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CLEC17A | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | MTX3 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |